Speculation Heats Up on Amarin Corporation PLC After Sales Force Hiring Delayed

Amarin Corp Plc (NASDAQ: AMRN) is higher early Thursday amid news the company is delaying the hiring of a sales force until December versus November. While on the surface this news would seem neutral-to-negative, speculators view this as an indications that talks with large pharma companies about a buyout or partnership to launch Vascepa are moving in the right direction. Also, this could indicate an NCE decision from the FDA is imminent. NCE status would likely push suitors over the top, although many analysts aren't certain it will be granted.

Back to news